155 related articles for article (PubMed ID: 36403606)
1. Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
Anand P; Schneeweiss S; Mostaghimi A; Schneeweiss MC
Pediatr Dermatol; 2023 Jan; 40(1):132-134. PubMed ID: 36403606
[TBL] [Abstract][Full Text] [Related]
2. Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.
Anand P; Schneeweiss S; Mostaghimi A; Schneeweiss MC
Pharmacoepidemiol Drug Saf; 2023 May; 32(5):567-576. PubMed ID: 36527432
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study.
Schneeweiss MC; Kim SC; Wyss R; Schneeweiss S; Merola JF
J Am Acad Dermatol; 2021 Feb; 84(2):300-311. PubMed ID: 33038471
[TBL] [Abstract][Full Text] [Related]
4. Management of inadequate response and adverse effects to dupilumab in atopic dermatitis.
Narla S; Silverberg JI; Simpson EL
J Am Acad Dermatol; 2022 Mar; 86(3):628-636. PubMed ID: 34126094
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis.
Schneeweiss MC; Perez-Chada L; Merola JF
J Am Acad Dermatol; 2021 Aug; 85(2):321-329. PubMed ID: 31158390
[TBL] [Abstract][Full Text] [Related]
6. Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis.
Ludwig CM; Hsiao JL; Lio PA; Shi VY
Dermatitis; 2021 Oct; 32(1S):S4-S7. PubMed ID: 33273236
[TBL] [Abstract][Full Text] [Related]
7. Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy.
Gori N; Chiricozzi A; Malvaso D; D'Urso DF; Caldarola G; De Simone C; Peris K
Dermatology; 2021; 237(4):535-541. PubMed ID: 33477153
[TBL] [Abstract][Full Text] [Related]
8. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
[TBL] [Abstract][Full Text] [Related]
9. Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Drucker AM; Ellis AG; Bohdanowicz M; Mashayekhi S; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI; Küster D; Siegels D; Schmitt J; Flohr C
JAMA Dermatol; 2020 Jun; 156(6):659-667. PubMed ID: 32320001
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in immunomodulators for atopic dermatitis.
Yim HJ; Jean T; Ong PY
Curr Opin Pediatr; 2023 Dec; 35(6):671-679. PubMed ID: 37522635
[TBL] [Abstract][Full Text] [Related]
11. Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study.
Schoder K; Zhu Y; Schneeweiss S; Merola JF; Savage TJ; Gibbs LR; Schneeweiss MC
J Am Acad Dermatol; 2023 Jul; 89(1):178-181. PubMed ID: 36905959
[No Abstract] [Full Text] [Related]
12. Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study.
Kridin K; Schonmann Y; Solomon A; Onn E; Bitan DT; Weinstein O; Cohen AD
Immunol Res; 2022 Feb; 70(1):106-113. PubMed ID: 34647194
[TBL] [Abstract][Full Text] [Related]
13. Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review.
Igelman S; Kurta AO; Sheikh U; McWilliams A; Armbrecht E; Jackson Cullison SR; Kress DW; Smith A; Castelo-Soccio L; Treat J; Boothe WD; Diaz LZ; Levy ML; Patel A; Lee LW; Fraile-Alonso MC; Antaya RJ; Shah S; Kittler N; Arkin L; Siegfried E
J Am Acad Dermatol; 2020 Feb; 82(2):407-411. PubMed ID: 31606479
[TBL] [Abstract][Full Text] [Related]
14. Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
de Bruin-Weller M; Pink AE; Ferrucci SM; Patrizi A; Svensson A; Schuttelaar MLA; Tauber M; Ardeleanu M; Jayawardena S; Daoud M
J Dermatolog Treat; 2022 Aug; 33(5):2565-2570. PubMed ID: 35255779
[TBL] [Abstract][Full Text] [Related]
15. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Sidbury R; Davis DM; Cohen DE; Cordoro KM; Berger TG; Bergman JN; Chamlin SL; Cooper KD; Feldman SR; Hanifin JM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Simpson EL; Tom WL; Williams HC; Elmets CA; Block J; Harrod CG; Begolka WS; Eichenfield LF;
J Am Acad Dermatol; 2014 Aug; 71(2):327-49. PubMed ID: 24813298
[TBL] [Abstract][Full Text] [Related]
16. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
[TBL] [Abstract][Full Text] [Related]
17. Dupilumab for the treatment of adolescents with atopic dermatitis.
Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
[TBL] [Abstract][Full Text] [Related]
18. [Current and upcoming treatments of adult atopic dermatitis].
Lacour JP
Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
[TBL] [Abstract][Full Text] [Related]
19. Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.
Schneeweiss MC; Wyss R; Schneeweiss S; Anand P; Jin Y; Dicesare E; Glynn RJ; Merola JF
J Am Acad Dermatol; 2024 Jan; 90(1):134-137. PubMed ID: 37604229
[No Abstract] [Full Text] [Related]
20. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
